A trading halt can last a few days, pauses usually a lot...

A trading halt can last a few days, pauses usually a lot quicker.
The Cupler research report is available on their website.

Culver claim Acadia have misrepresented Daybues safety profile. They've used pretty colourful terminology / language 'horror' stories.
Interesting that then then still see annualised sales of circa $230m annually out to 2030.
So they need to decide, is their call a binary one? It either works or it doesn't.

Many of the side effects they claim were included in the NEU release, so not a lot of new news there.
It's not a particularly well balanced research report in my view, but as a shareholder one might claim I'm not being as objective as I might otherwise be.

I expect a key barometer going forward will be whether insurance companies continue to reimburse and any definitive feedback on that front.